A total of 2306 patients were enrolled in the initial open-label phase of the study. Of these, 627 patients who showed a suboptimal response after 8 weeks of treatment with olmesartan medoxomil 20 ...
Parsippany, NJ (May 27, 2005) – Data from two clinical studies presented at the American Society of Hypertension's Twentieth Annual Scientific Meeting (ASH 2005) in San Francisco demonstrated that ...
Amlodipine (as besylate) 5 mg, olmesartan medoxomil 20 mg; tabs. Amlodipine is a calcium channel blocker in the dihydropyridine class. It works by inhibiting the influx of calcium ions into vascular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results